David L Mahoney Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 13 hours ago
David L Mahoney has an estimated net worth of at least $156.4 million*, as of Sept. 2, 2026. They own 1.2 million shares of CORT stock. They have sold 175,958 shares of CORT stock since 2021, for an estimated $16.7 million.
David L Mahoney $CORT SEC Form 4 Insider Trading
David L Mahoney has filed a total of 9 insider trades in $CORT since 2021. Their most recent trade was a sale of 4,984 shares, made on Aug 18, 2026. Their largest trade was a sale of 91,167 shares, made on Aug 18, 2026. We estimate that they now own 1.2 million shares of $CORT, worth an estimated $139.7 million.
Insider Trading at $CORT
There have been a total of 294 insider trades reported at $CORT since 2021, with 400,000 shares purchased and 3.4 million shares sold. The most active insider traders in $CORT stock have been Sean Maduck, William Guyer, and Joseph K Belanoff. The most recent trade was a sale of 2,281 shares reported by Sean Maduck (See Remarks), made on Sep 01, 2026.
History of Insider Stock Trades by David L Mahoney
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CORT
|
Sale | 4,984 | Aug 18, 2026 | Aug. 20, 2026, 4:30 p.m. |
|
CORT
|
Sale | 400 | Aug 18, 2026 | Aug. 20, 2026, 4:30 p.m. |
|
CORT
|
Sale | 7,055 | Aug 18, 2026 | Aug. 20, 2026, 4:30 p.m. |
|
CORT
|
Sale | 91,167 | Aug 18, 2026 | Aug. 20, 2026, 4:30 p.m. |
|
CORT
|
Sale | 20,000 | Jun 17, 2026 | June 18, 2026, 4:30 p.m. |
|
CORT
|
Sale | 3,523 | May 16, 2025 | May 20, 2025, 7:13 p.m. |
|
CORT
|
Sale | 23,829 | May 16, 2025 | May 20, 2025, 7:13 p.m. |
|
CORT
|
Sale | 10,000 | Aug 14, 2023 | Aug. 16, 2023, 4:53 p.m. |
|
CORT
|
Sale | 15,000 | Aug 14, 2023 | Aug. 16, 2023, 4:53 p.m. |
$CORT Executives and Stock Owners with Insider Trades
-
Sean Maduck, See Remarks
-
William Guyer, Chief Development Officer
-
Joseph K Belanoff, Chief Executive Officer
-
Joseph Douglas Lyon, See Remarks
-
Gary Charles Robb, Chief Business Officer
-
Atabak Mokari, Chief Financial Officer
-
Joseph Douglas Lyon, Chief Accounting Officer
-
Roberto Wandenkolk Vieira, President, Oncology
-
Sean Maduck, Chief Commercial Officer
-
Hazel Hunt, Chief Scientific Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.